Matthew Cafer

Matthew leads the software, data and AI/ML division at Cavenagh Health. Through his career he has worked closely with the UKs leading tech-bio and biotech companies to establish leadership and engineering teams capable of taking products and technology forward through development. Over the course of Matthew’s career he has seen the rapid rise, impact and critical need for the utilisation of AI and ML for the industry to accelerate products towards patients.

1 Articles Published | Follow:
Unravelling the most complex disease challenges in history: how AI startups are changing drug discovery

Throughout history, science has been our tool for unravelling the complexities of life and improving medical treatments, including how cells interact, chemical reactions unfold, and drugs bind to their targets. In recent years, artificial intelligence (AI) has taken this to a new level. By collecting and processing vast amounts of data, AI is helping us identify new therapeutic targets and create treatments on an entirely different scale.